Non small cell lung cancer other imaging findings
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Overview
Overview
Other imaging findings of non-small cell lung cancer include PET and pulmonary angiography.
Other Imaging Findings
Other Imaging Findings
PET
PET scanning with the tracer fluorine-18 (F-18) fluorodeoxyglucose (FDG), called FDG-PET, is widely used in the diagnosis of non-small cell lung cancer, for the following reasons:[1][2]
- General follow-up
- Characterization of treatment response
- Staging modality (in the risk of missing occult disease)
- Findings associated with non-small cell lung cancer on PET/CT include:
- The CT scan demonstrates abnormalities such as a lung nodule or enlarged lymph nodes. Whereas, the PET scan reveals increased metabolism in structures which contain rapidly growing cancer cells
- Intense radiolabeling of tissues with high glucose uptake, such as the brain, the liver, and malignant tumor cells.
Pulmonary Angiography
- On pulmonary angiography, findings of non-small cell lung cancer, include:[3]
- Evaluation of central pulmonary artery invasion
References
References
- ↑ Shim SS, Lee KS, Kim BT, Chung MJ, Lee EJ, Han J, Choi JY, Kwon OJ, Shim YM, Kim S (2005). “Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging”. Radiology. 236 (3): 1011–9. doi:10.1148/radiol.2363041310. PMID 16014441.
- ↑ Steinert HC (2011). “PET and PET-CT of lung cancer”. Methods Mol. Biol. 727: 33–51. doi:10.1007/978-1-61779-062-1_3. PMID 21331927.
- ↑ Delarue NC, Sanders DE, Silverberg SA (1970). “Complementary value of pulmonary angiography and mediastinoscopy in individualizing treatment for patients with lung cancer”. Cancer. 26 (6): 1370–8. PMID 5483666.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH